You eat what you are: Autophagy inhibition as a therapeutic strategy in leukemia

70Citations
Citations of this article
99Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A deeper understanding of the role of autophagy, literally 'self-eating', in normal and cancer cell biology has emerged over the last few years. Autophagy serves as a vehicle for cells to respond to various stressors including genomic, hypoxic and nutrient stress, and to oppose mechanisms of 'programmed' cell death. Here, we review not only mechanisms of cell death and cell survival but also the early successes in applying autophagy inhibition strategies in solid tumors using the only currently available clinical inhibitor, oral hydroxychloroquine. In acute leukemia, currently available chemotherapy drugs promote cell death and demonstrate clinical benefit, but relapse and subsequent chemotherapy resistance is common. Increasing preclinical data suggest that autophagy is active in leukemia as a means of promoting cell survival in response to chemotherapy. We propose coupling autophagy inhibition strategies with current cytotoxic chemotherapy and discuss synergistic combinations of available anti-leukemic therapies with autophagy inhibition. Furthermore, novel autophagy inhibitors are in development and promise to provide new therapeutic opportunities for patients with leukemia.

References Powered by Scopus

Cancer statistics, 2014

11479Citations
N/AReaders
Get full text

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing

5863Citations
N/AReaders
Get full text

Autophagy fights disease through cellular self-digestion

5690Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents

384Citations
N/AReaders
Get full text

Repurposing drugs in oncology (ReDO) - Chloroquine and hydroxychloroquine as anti-cancer agents

195Citations
N/AReaders
Get full text

PML at Mitochondria-Associated Membranes Is Critical for the Repression of Autophagy and Cancer Development

132Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sehgal, A. R., Konig, H., Johnson, D. E., Tang, D., Amaravadi, R. K., Boyiadzis, M., & Lotze, M. T. (2015, March 9). You eat what you are: Autophagy inhibition as a therapeutic strategy in leukemia. Leukemia. Nature Publishing Group. https://doi.org/10.1038/leu.2014.349

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 34

55%

Researcher 15

24%

Professor / Associate Prof. 11

18%

Lecturer / Post doc 2

3%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 24

38%

Agricultural and Biological Sciences 19

30%

Medicine and Dentistry 15

24%

Pharmacology, Toxicology and Pharmaceut... 5

8%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free